Inflammatory Biomarkers, Statins, and the Risk of Stroke
- 4 June 2002
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (22), 2583-2585
- https://doi.org/10.1161/01.cir.0000017822.82512.62
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Effects of Cholesterol and Inflammation-Sensitive Plasma Proteins on Incidence of Myocardial Infarction and Stroke in MenCirculation, 2002
- Effect of Statin Therapy on C-Reactive Protein LevelsJAMA, 2001
- Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin siteNature Medicine, 2001
- Statins as a newly recognized type of immunomodulatorNature Medicine, 2000
- Pravastatin Therapy and the Risk of StrokeNew England Journal of Medicine, 2000
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Effect of Simvastatin on Ischemic Signs and Symptoms in the Scandinavian Simvastatin Survival Study (4S)The American Journal of Cardiology, 1998
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Prospective study of endogenous tissue plasminogen activator and risk of strokeThe Lancet, 1994
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984